tiprankstipranks
Agios Pharmaceuticals Reports Q1 2025 Progress and Outlook
PremiumCompany AnnouncementsAgios Pharmaceuticals Reports Q1 2025 Progress and Outlook
1M ago
Agios Pharmaceuticals’ Earnings Call: Optimism Amid Challenges
Premium
Company Announcements
Agios Pharmaceuticals’ Earnings Call: Optimism Amid Challenges
1M ago
Agios Pharma’s Strategic Advances and Mitapivat’s Market Potential Drive Buy Rating
Premium
Ratings
Agios Pharma’s Strategic Advances and Mitapivat’s Market Potential Drive Buy Rating
1M ago
Alibaba upgraded, Rivian downgraded: Wall Street’s top analyst calls
PremiumThe FlyAlibaba upgraded, Rivian downgraded: Wall Street’s top analyst calls
4M ago
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
Premium
The Fly
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
4M ago
Agios Pharmaceuticals price target lowered to $74 from $75 at Scotiabank
Premium
The Fly
Agios Pharmaceuticals price target lowered to $74 from $75 at Scotiabank
4M ago
Agios Pharmaceuticals reports results from Phase 3 ACTIVATE-Kids study
PremiumThe FlyAgios Pharmaceuticals reports results from Phase 3 ACTIVATE-Kids study
4M ago
Agios Pharma Board Member Announces Resignation
Premium
Company Announcements
Agios Pharma Board Member Announces Resignation
4M ago
Agios Pharmaceuticals price target lowered to $54 from $55 at BofA
Premium
The Fly
Agios Pharmaceuticals price target lowered to $54 from $55 at BofA
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100